| 1 |
吴国明，钱桂生. 非小细胞肺癌靶向治疗研究进展及新理念[J/CD]. 中华肺部疾病杂志(电子版), 2019, 12(4): 405-408.
|
| 2 |
马蓉蓉，明宗娟，李 维，等. 肺腺癌病理类型转化特征及耐药机制分析[J/CD]. 中华肺部疾病杂志(电子版), 2022，15(6): 782-786.
|
| 3 |
Tamura T, Kurishima K, Nakazawa K, et al. Specific organ metastases and survival in metastatic non-small-cell lung cancer[J]. Mol Clin Oncol, 2015, 3(1): 217-221.
|
| 4 |
Ko EC, Raben D, Formenti SCJC. The integration of radiotherapy with immunotherapy for the treatment of non-small cell lung cancer[J]. Clin Cancer Res, 2018, 24(23): 5792-5806.
|
| 5 |
Liu J, Xiao Q, Xiao J, et al. Wnt/β-catenin signalling: function, biological mechanisms, and therapeutic opportunities[J]. Signal Transduct Target Ther, 2022, 7(1): 3.
|
| 6 |
Agostino M, Pohl SÖ. The structural biology of canonical Wnt signalling[J]. Biochem Soc Trans, 2020, 48(4): 1765-1780.
|
| 7 |
Zheng H, Ning Y, Yang Y, et al. Aberrant expression of β-catenin correlates with infiltrating immune cells and prognosis in NSCLC[J]. Pathol Oncol Res, 2021, 27: 1609981.
|
| 8 |
Stewart DJ. Wnt signaling pathway in non-small cell lung cancer[J]. J Natl Cancer Inst, 2014, 106(1): t356.
|
| 9 |
Das B, Sinha D. Diallyl disulphide suppresses the cannonical Wnt signaling pathway and reverses the fibronectin-induced epithelial mesenchymal transition of A549 lung cancer cells[J]. Food Funct, 2019, 10(1): 191-202.
|
| 10 |
Lamouille S, Xu J, Derynck RJNR. Molecular mechanisms of epithelial-mesenchymal transition[J]. Nat Rev Mol Cell Biol, 2014, 15(3): 178-196.
|
| 11 |
Valenta T, Hausmann G, Basler K. The many faces and functions of β-catenin[J]. EMBO J, 2012, 31(12): 2714-2736.
|
| 12 |
Shi J, Li C, Wang H, et al. NUP58 facilitates metastasis and epithelial-mesenchymal transition of lung adenocarcinoma via the GSK-3β/Snail signaling pathway[J]. Am J Transl Res, 2019, 11(1): 393-405.
|
| 13 |
Hu Y, Mu H, Yang Y. Histone demethylase PHF8 promotes cell growth and metastasis of non-small-cell lung cancer through activating Wnt/β-catenin signaling pathway[J]. Histol Histopathol, 2021, 36(8): 869-877.
|
| 14 |
Yang Y, Sun Y, Wu Y, et al. Downregulation of miR-3127-5p promotes epithelial-mesenchymal transition via FZD4 regulation of Wnt/β-catenin signaling in non-small-cell lung cancer[J]. Mol Carcinog, 2018, 57(7): 842-853.
|
| 15 |
Yang S, Liu Y, Li M Y, et al. FOXP3 promotes tumor growth and metastasis by activating Wnt/β-catenin signaling pathway and EMT in non-small cell lung cancer[J]. Mol Cancer, 2017, 16(1): 124.
|
| 16 |
Huang JQ, Wei FK, Xu XL, et al. SOX9 drives the epithelial-mesenchymal transition in non-small-cell lung cancer through the Wnt/β-catenin pathway[J]. J Transl Med, 2019, 17(1): 143.
|
| 17 |
Xue S, Wu W, Wang Z, et al. USP5 promotes metastasis in non-small cell lung cancer by inducing epithelial-mesenchymal transition via Wnt/β-catenin pathway[J]. Front Pharmacol, 2020, 11: 668.
|
| 18 |
Xia C, Xu X, Ding Y, et al. Abnormal spindle-like microcephaly-associated protein enhances cell invasion through Wnt/β-catenin-dependent regulation of epithelial-mesenchymal transition in non-small cell lung cancer cells[J]. J Thorac Dis, 2021, 13(4): 2460-2474.
|
| 19 |
Olsen JJ, Pohl SÖ，Deshmukh A, et al. The role of wnt sgnalling in angiogenesis[J]. Clin Biochem Rev, 2017, 38(3): 131-142.
|
| 20 |
Judit R. The role of wnt signaling in the decelopment and treatment of non-small cell lung cancer[D]. University of Pécs, 2017: 78-96.
|
| 21 |
Shukla S, Sinha S, Khan S, et al. Cucurbitacin B inhibits the stemness and metastatic abilities of NSCLC via downregulation of canonical Wnt/β-catenin signaling axis[J]. Sci Rep, 2016, 6: 21860.
|
| 22 |
Fernández Jaime G, Rodríguez Diego A, Valenzuela Manuel, et al. Survivin expression promotes VEGF-induced tumor angiogenesis via PI3K/Akt enhanced β-catenin/Tcf-Lef dependent transcription[J]. Mol Cancer, 2014, 13: 209.
|
| 23 |
Yeo Eun-Jin, Cassetta Luca, Qian Bin-Zhi, et al. Myeloid WNT7b mediates the angiogenic switch and metastasis in breast cancer[J]. Cancer Res, 2014, 74(11): 2962-2973.
|
| 24 |
Huang CL, Liu D, Ishikawa S, et al. Wnt1 overexpression promotes tumour progression in non-small cell lung cancer[J]. Eur J Cancer, 2008, 44(17): 2680-2688.
|
| 25 |
Rapp Judit, Jaromi Luca, Kvell Krisztian, et al. WNT signaling-lung cancer is no exception[J]. Respir Res, 2017, 18(1): 167.
|
| 26 |
Choe Youngshik, Pleasure Samuel J. Wnt signaling regulates intermediate precursor production in the postnatal dentate gyrus by regulating CXCR4 expression[J]. Dev Neurosci, 2012, 34(6): 502-514.
|
| 27 |
Nguyen Don X, Chiang Anne C, Zhang Xiang H-F, et al. WNT/TCF signaling through LEF1 and HOXB9 mediates lung adenocarcinoma metastasis[J]. Cell, 2009, 138(1): 51-62.
|
| 28 |
Li Huanhuan, Tong Fan, Meng Rui, et al. E2F1-mediated repression of WNT5A expression promotes brain metastasis dependent on the ERK1/2 pathway in EGFR-mutant non-small cell lung cancer[J]. Cell Mol Life Sci, 2021, 78(6): 2877-2891.
|
| 29 |
Zhang Hui-Juan, Chang Wen-Jing, Jia Cai-Yun, et al. Destrin contributes to lung adenocarcinoma progression by activating Wnt/β-catenin signaling pathway[J]. Mol Cancer Res, 2020，18(12): 1789-1802.
|
| 30 |
She Kelin, Yang Wensheng, Li Mengna, et al. FAIM2 Promotes non-small cell lung cancer cell growth and bone metastasis by activating the Wnt/β-catenin pathway[J]. Front Oncol, 2021, 11: 690142.
|
| 31 |
Liu Liyun, Zhu Hongrui, Liao Yahui, et al. Inhibition of Wnt/β-catenin pathway reverses multi-drug resistance and EMT in Oct4(+)/Nanog(+) NSCLC cells[J]. Biomed Pharmacother, 2020, 127: 110225.
|
| 32 |
Gong Liyun, Song Junwei, Lin Xi, et al. Serine-arginine protein kinase 1 promotes a cancer stem cell-like phenotype through activation of Wnt/β-catenin signalling in NSCLC[J]. J Pathol, 2016, 240(2): 184-196.
|
| 33 |
Shu Xiong, Chen Meng, Liu Shi-Ya, et al. Palladin promotes cancer stem cell-like properties in lung cancer by activating Wnt/β-catenin signaling[J]. Cancer Med, 2022, 12(4): 4510-4520.
|
| 34 |
Su Jie, Wu Shifei, Wu Haiyang, et al. CD44 is functionally crucial for driving lung cancer stem cells metastasis through Wnt/β-catenin-FoxM1-Twist signaling[J]. Mol Carcinog, 2016, 55(12): 1962-1973.
|
| 35 |
Ma Yunxia, Marinkova Rumyana, Nenkov Miljana, et al. Tumor-intrinsic PD-L1 exerts an oncogenic function through the activation of the Wnt/β-catenin pathway in human non-small cell lung cancer[J]. Int J Mol Sci, 2022, 23(19): 11031.
|
| 36 |
Scheel Andreas H, Ansén Sascha, Schultheis Anne M, et al. PD-L1 expression in non-small cell lung cancer: Correlations with genetic alterations[J]. Oncoimmunology, 2016, 5(5): e1131379.
|
| 37 |
Hung Pei-Shan, Huang Ming-Hung, Kuo Yuan-Yeh, et al. The inhibition of wnt restrain KRAS(G12V)-driven metastasis in non-small-cell lung cancer[J]. Cancers (Basel), 2020, 12(4): 837.
|
| 38 |
Wang Qiang, Liao Jinrong, He Zhiyong, et al. LHX6 affects erlotinib resistance and migration of EGFR-mutant non-small-cell lung cancer HCC827 cells through suppressing Wnt/β-catenin signaling[J]. Onco Targets Ther, 2020, 13: 10983-10994.
|
| 39 |
Cai Junchao, Fang Lishan, Huang Yongbo, et al. Publisher Correction：Simultaneous overactivation of Wnt/β-catenin and TGFβ signalling by miR-128-3p confers chemoresistance-associated metastasis in NSCLC[J]. Nat Commun, 2018, 9: 16196.
|
| 40 |
Wang Yang, He Bo, Dong Yan, et al. Homeobox-A13 acts as a functional prognostic and diagnostic biomarker via regulating P53 and Wnt signaling pathways in lung cancer[J]. Cancer Biomark, 2021, 31(3): 239-254.
|
| 41 |
Jiang Neng, Zou Chang, Zhu Ying, et al. HIF-1ɑ-regulated miR-1275 maintains stem cell-like phenotypes and promotes the progression of LUAD by simultaneously activating Wnt/β-catenin and Notch signaling[J]. Theranostics, 2020, 10(6): 2553-2570.
|
| 42 |
Johnson Rachelle W, Merkel Alyssa R, Page Jonathan M, et al. Wnt signaling induces gene expression of factors associated with bone destruction in lung and breast cancer[J]. Clin Exp Metastasis, 2014, 31(8): 945-959.
|